Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DW-3101 for Gastric Inflammation
NCT02386007Phase 2Unknown
- Sponsor
- Daewon Pharm
- Primary completion
- Jul 2017
- Modality
- PE (Plant Extract), Dietary Supplement, Food
01
Overview
A Phase 2 trial of opuntia ficus-indica in gastritis, sponsored by Daewon Pharm. Status: unknown.
02
Drugs
opuntia ficus-indica
03
Conditions
gastritis
Beyond the preview
Go deeper on NCT02386007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02386007.